NCT01137552View on ClinicalTrials.gov

A Phase 1 Dose Escalation Study of AMG 780 in Adult Subjects With Advanced Solid Tumors

PHASE1TerminatedINTERVENTIONAL

Enrollment

44

Participants

Timeline

Start Date

June 30, 2010

Primary Completion Date

December 31, 2013

Study Completion Date

April 30, 2014

Conditions

Advanced Solid Tumors

Interventions

DRUG

AMG 780

AMG 780 will be administered by IV infusion every 2 weeks

Trial Locations (3)

27710

Research Site, Durham

44106

Research Site, Cleveland

90048

Research Site, Los Angeles

Sponsors

Lead Sponsor

All Listed Sponsors

lead

Amgen

INDUSTRY